Literature DB >> 28168595

Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist.

Joanna Quigley1.   

Abstract

Juvenile Huntington's disease (JHD) is a neurodegenerative disease with onset prior to the age of 21. While it accounts for a relatively small proportion of Huntington's disease (HD) diagnoses, its impact is significant on the quality of life for those affected. Clinicians may be unaware that HD can present in childhood and adolescence, delaying diagnosis. HD develops due to an expanded CAG repeat in the huntington gene. Rigidity, dystonia, and seizures are more common in JHD. Cognitive changes such as executive function impairments and decline in school performance are common. The burden of psychiatric symptoms is considerable and includes depression, anxiety, impulsivity, and aggression. While novel approaches to treatment interventions are investigated, current care is limited to targeting symptoms rather than disease modification. Prompt diagnosis and symptomatic treatment can maximize quality of life for these patients.

Entities:  

Keywords:  Anxiety; Chorea; Depression; Juvenile Huntington’s disease; Neurodegenerative; Neuropsychiatric; Rigidity

Mesh:

Year:  2017        PMID: 28168595     DOI: 10.1007/s11920-017-0759-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  21 in total

1.  Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia.

Authors:  Szu-Chia Lai; Shih-Ming Jung; Padraic Grattan-Smith; Ella Sugo; Yen-Wen Lin; Rou-Shayn Chen; Chiung-Chu Chen; Yah-Huei Wu-Chou; Anthony E Lang; Chin-Song Lu
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 2.  Huntington's disease in children.

Authors:  Derek Letort; Pedro Gonzalez-Alegre
Journal:  Handb Clin Neurol       Date:  2013

3.  Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume.

Authors:  Gaël Nicolas; Didier Devys; Alice Goldenberg; David Maltête; Catherine Hervé; Didier Hannequin; Lucie Guyant-Maréchal
Journal:  Am J Med Genet A       Date:  2011-03-15       Impact factor: 2.802

4.  Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature.

Authors:  Pedro Gonzalez-Alegre; Adel K Afifi
Journal:  J Child Neurol       Date:  2006-03       Impact factor: 1.987

5.  Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Authors:  Samuel Frank; Claudia M Testa; David Stamler; Elise Kayson; Charles Davis; Mary C Edmondson; Shari Kinel; Blair Leavitt; David Oakes; Christine O'Neill; Christina Vaughan; Jody Goldstein; Margaret Herzog; Victoria Snively; Jacquelyn Whaley; Cynthia Wong; Greg Suter; Joseph Jankovic; Joohi Jimenez-Shahed; Christine Hunter; Daniel O Claassen; Olivia C Roman; Victor Sung; Jenna Smith; Sarah Janicki; Ronda Clouse; Marie Saint-Hilaire; Anna Hohler; Denyse Turpin; Raymond C James; Ramon Rodriguez; Kyle Rizer; Karen E Anderson; Hope Heller; Alexis Carlson; Susan Criswell; Brad A Racette; Fredy J Revilla; Frederick Nucifora; Russell L Margolis; MaryJane Ong; Tilak Mendis; Neila Mendis; Carlos Singer; Monica Quesada; Jane S Paulsen; Thomas Brashers-Krug; Amanda Miller; Jane Kerr; Richard M Dubinsky; Carolyn Gray; Stewart A Factor; Elaine Sperin; Eric Molho; Mary Eglow; Sharon Evans; Rajeev Kumar; Christina Reeves; Ali Samii; Sylvain Chouinard; Monica Beland; Burton L Scott; Patrick T Hickey; Sherali Esmail; Wai Lun Alan Fung; Clare Gibbons; Lina Qi; Amy Colcher; Cory Hackmyer; Andrew McGarry; Kevin Klos; Mark Gudesblatt; Lori Fafard; Laura Graffitti; Daniel P Schneider; Rohit Dhall; Joanne M Wojcieszek; Kathrin LaFaver; Andrew Duker; Erin Neefus; Hilary Wilson-Perez; David Shprecher; Paola Wall; Karen A Blindauer; Lynn Wheeler; James T Boyd; Emily Houston; Eric S Farbman; Pinky Agarwal; Shirley W Eberly; Arthur Watts; Pierre N Tariot; Andrew Feigin; Scott Evans; Chris Beck; Constance Orme; Jon Edicola; Emily Christopher
Journal:  JAMA       Date:  2016-07-05       Impact factor: 56.272

6.  Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.

Authors:  Pascale Ribaï; Karine Nguyen; Valérie Hahn-Barma; Isabelle Gourfinkel-An; Marie Vidailhet; Antoine Legout; Catherine Dodé; Alexis Brice; Alexandra Dürr
Journal:  Arch Neurol       Date:  2007-06

7.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

8.  Current Pharmacological Management in Juvenile Huntington's Disease.

Authors:  Lisa Robertson; Helen Santini; Kirsty L O'Donovan; Ferdinando Squitieri; Roger A Barker; Maria Rakowicz; G Bernhard Landwehrmeyer; Oliver Quarrell
Journal:  PLoS Curr       Date:  2012-02-15

Review 9.  Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells.

Authors:  Peter Deng; Audrey Torrest; Kari Pollock; Heather Dahlenburg; Geralyn Annett; Jan A Nolta; Kyle D Fink
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

10.  Juvenile Huntington's disease: a population-based study using the General Practice Research Database.

Authors:  Ian Douglas; Stephen Evans; Michael D Rawlins; Liam Smeeth; Sarah J Tabrizi; Nancy S Wexler
Journal:  BMJ Open       Date:  2013-04-03       Impact factor: 2.692

View more
  7 in total

1.  Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.

Authors:  Sonia Di Tella; Maria RIta Lo Monaco; Martina Petracca; Paola Zinzi; Marcella Solito; Carla Piano; Paolo Calabresi; Maria Caterina Silveri; Anna Rita Bentivoglio
Journal:  J Neurol       Date:  2022-08-01       Impact factor: 6.682

2.  The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function.

Authors:  Wojciech J Szlachcic; Kalina Wiatr; Marta Trzeciak; Marek Figlerowicz; Maciej Figiel
Journal:  Front Mol Neurosci       Date:  2017-08-08       Impact factor: 5.639

Review 3.  Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.

Authors:  Ewelina Latoszek; Magdalena Czeredys
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 4.  Innovative Therapeutic Approaches for Huntington's Disease: From Nucleic Acids to GPCR-Targeting Small Molecules.

Authors:  Hidetoshi Komatsu
Journal:  Front Cell Neurosci       Date:  2021-11-26       Impact factor: 5.505

5.  Effect of Immersive Virtual Reality by a Computer Assisted Rehabilitation Environment (CAREN) in Juvenile Huntington's Disease: A Case Report.

Authors:  Roberta Cellini; Giuseppe Paladina; Giacomo Mascaro; Maria Antonietta Lembo; Antonino Lombardo Facciale; Maria Cristina Ferrera; Bartolo Fonti; Luca Pergolizzi; Piero Buonasera; Placido Bramanti; Emanuela Mazzon
Journal:  Medicina (Kaunas)       Date:  2022-07-11       Impact factor: 2.948

6.  Behavioral Deficits in Juvenile Onset Huntington's Disease.

Authors:  Kathleen E Langbehn; Ashley M Cochran; Ellen van der Plas; Amy L Conrad; Eric Epping; Erin Martin; Patricia Espe-Pfeifer; Peg Nopoulos
Journal:  Brain Sci       Date:  2020-08-11

Review 7.  Juvenile Huntington's disease: two case reports and a review of the literature.

Authors:  Sigita Lesinskienė; Darja Rojaka; Rūta Praninskienė; Aušra Morkūnienė; Aušra Matulevičienė; Algirdas Utkus
Journal:  J Med Case Rep       Date:  2020-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.